Hospital Pharmacists’ Attitudes and Intentions Toward Adverse Drug Reaction Reporting in Saudi Arabia: Insights from the Theory of Planned Behavior
Abstract
:1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Study Instruments
2.2.1. TPB Constructs
2.2.2. Perceived Moral Obligation
2.3. Statistical Analysis
3. Results
3.1. Respondent Profile
3.2. Intention to Report ADRs
3.3. TPB Constructs and Perceived Moral Obligation
3.4. ADR Reporting Intentions Among Hospital Pharmacists by Category
3.5. Predictors Associated with the Intention of Hospital Pharmacists to Report ADRs
4. Discussion
5. Limitations
6. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
ADRs | adverse drug reactions |
NPC | National Pharmacovigilance Center |
SFDA | Saudi Food and Drug Authority |
HCPs | Healthcare Providers |
WHO | World Health Organization |
TPB | theory of planned behavior |
References
- WHO. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions: Why Health Professionals Need to Take Action; WHO: Geneva, Switzerland, 2002. [Google Scholar]
- Suyagh, M.; Farah, D.; Farha, R.A. Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm. J. 2015, 23, 147–153. [Google Scholar] [CrossRef] [PubMed]
- Khan, Z.; Muhammad, K.; Karatas, Y.; Bilen, C.; Khan, F.U.; Khan, F.U. Pharmacovigilance and incidence of adverse drug reactions in hospitalized pediatric patients: A mini systematic review. Egypt. Pediatr. Assoc. Gaz. 2020, 68, 1–7. [Google Scholar] [CrossRef]
- Nobili, A.; Licata, G.; Salerno, F.; Pasina, L.; Tettamanti, M.; Franchi, C.; De Vittorio, L.; Marengoni, A.; Corrao, S.; Iorio, A. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur. J. Clin. Pharmacol. 2011, 67, 507–519. [Google Scholar] [CrossRef] [PubMed]
- Le Louët, H.; Pitts, P.J. Twenty-first century global ADR management: A need for clarification, redesign, and coordinated action. Ther. Innov. Regul. Sci. 2023, 57, 100–103. [Google Scholar] [CrossRef]
- Alayed, N.; Alkhalifah, B.; Alharbi, M.; Alwohaibi, N.; Farooqui, M. Adverse drug reaction (ADR) as a cause of hospitalization at a government hospital in Saudi Arabia: A prospective observational study. Curr. Drug Saf. 2019, 14, 192–198. [Google Scholar] [CrossRef] [PubMed]
- Randhawa, M.A.; Qutub, H.O.; Alghamdi, M.S.; Al-Jaizani, R.A.; Mushtaq, R.Y.; Akbar, M.J. Drug related problems at the intensive care unit of a university hospital in Saudi Arabia. Saudi J. Intern. Med. 2015, 5, 11–18. [Google Scholar] [CrossRef]
- Al-Arifi, M.; Abu-Hashem, H.; Al-Meziny, M.; Said, R.; Aljadhey, H. Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia. Saudi Pharm. J. 2014, 22, 17–25. [Google Scholar] [CrossRef]
- Zdrowia, Ś.O. The Importance of Pharmacovigilance: Safety Monitoring of Medicinal Products; World Health Organization: Geneva, Switzerland, 2002. [Google Scholar]
- Alharf, A.; Alqahtani, N.; Saeed, G.; Alshahrani, A.; Alshahrani, M.; Aljasser, N.; Alquwaizani, M.; Bawazir, S. Saudi vigilance program: Challenges and lessons learned. Saudi Pharm. J. 2018, 26, 388–395. [Google Scholar] [CrossRef]
- Sultana, J.; Cutroneo, P.; Trifirò, G. Clinical and economic burden of adverse drug reactions. J. Pharmacol. Pharmacother. 2013, 4, S73–S77. [Google Scholar] [CrossRef]
- Alshammari, T.M.; Alshakka, M.; Aljadhey, H. Pharmacovigilance system in Saudi Arabia. Saudi Pharm. J. 2017, 25, 299–305. [Google Scholar] [CrossRef]
- Ahmad, S.R. Pharmacovigilance bolstered in the Arab world. Lancet 2014, 384, e63. [Google Scholar] [CrossRef]
- World Development Indicators; World Bank: Washington, DC, USA, 2023.
- Van Grootheest, A.; De Jong-van den Berg, L. The role of hospital and community pharmacists in pharmacovigilance. Res. Soc. Adm. Pharm. 2005, 1, 126–133. [Google Scholar] [CrossRef] [PubMed]
- Hepler, C.D.; Strand, L.M. Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 1990, 47, 533–543. [Google Scholar] [CrossRef] [PubMed]
- Lemay, J.; Alsaleh, F.M.; Al-Buresli, L.; Al-Mutairi, M.; Abahussain, E.A.; Bayoud, T. Reporting of adverse drug reactions in primary care settings in Kuwait: A comparative study of physicians and pharmacists. Med. Princ. Pract. 2018, 27, 30–38. [Google Scholar] [CrossRef]
- Khan, T.M. Community pharmacists’ knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther. Adv. Drug Saf. 2013, 4, 45–51. [Google Scholar] [CrossRef]
- Alshabi, A.M.; Shaikh, M.A.K.; Shaikh, I.A.; Alkahtani, S.A.; Aljadaan, A. Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia. Saudi Pharm. J. 2022, 30, 1018–1026. [Google Scholar] [CrossRef]
- Mahmoud, M.A.; Alswaida, Y.; Alshammari, T.; Khan, T.M.; Alrasheedy, A.; Hassali, M.A.; Aljadhey, H. Community pharmacists’ knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm. J. 2014, 22, 411–418. [Google Scholar] [CrossRef] [PubMed]
- Al Doughan, F.F.; Alomi, Y.A.; Iflaifel, M.H. Pharmacist’s Practice of Reporting of Adverse Drug Reactions in Saudi Arabia. Int. J. Pharmacol. Clin. Sci. 2019, 2, 86–93. [Google Scholar] [CrossRef]
- Alsheikh, M.Y.; Alasmari, M.M. A National Survey of Community Pharmacists’ Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia. Front. Pharmacol. 2022, 13, 819551. [Google Scholar] [CrossRef]
- Ajzen, I. The theory of planned behavior. Organ. Behav. Hum. Decis. Process. 1991, 50, 179–211. [Google Scholar] [CrossRef]
- Gavaza, P.; Brown, C.M.; Lawson, K.A.; Rascati, K.L.; Wilson, J.P.; Steinhardt, M. Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res. Soc. Adm. Pharm. 2011, 7, 369–382. [Google Scholar] [CrossRef]
- Raghvan, H.P.N.; Fatokun, O. Factors associated with the intention of community pharmacists to report adverse drug reactions to regulatory authority in Malaysia: Application of the theory of planned behaviour. Int. J. Pharm. Pract. 2021, 29, 435–442. [Google Scholar] [CrossRef]
- Ministry of Health, Kingdom of Saudi Arabia. Statistical Yearbook 2023. 2023. Available online: https://www.moh.gov.sa/en/Ministry/Statistics/book/Documents/Statistical-Yearbook-2023.pdf (accessed on 15 April 2025).
- Bates, D.W. Drugs and adverse drug reactions: How worried should we be? Jama 1998, 279, 1216–1217. [Google Scholar] [CrossRef] [PubMed]
- Bonn, D. Adverse drug reactions remain a major cause of death. Lancet 1998, 351, 1183. [Google Scholar] [CrossRef] [PubMed]
- Tadvi, N.A.; Alromaih, A.A.; Aldahash, A.A.; Almuhesseny, A.A.; Alotaibi, S.H.; Alduhayshi, I.S.; Alrukimi, A.S.; Sami, W. Knowledge, attitude and practice of pharmacovigilance in healthcare professionals and medical students in Majmaah, Saudi Arabia Care Centre. Health Sci. 2018, 7, 101–107. [Google Scholar]
- Ali, M.D.; Hassan, Y.A.; Ahmad, A.; Alaqel, O.; Al-Harbi, H.; Al-Suhaimi, N.M. Knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process among health care providers in Dammam, Saudi Arabia. Curr. Drug Saf. 2018, 13, 21–25. [Google Scholar] [CrossRef]
- Alsaleh, F.M.; Alzaid, S.W.; Abahussain, E.A.; Bayoud, T.; Lemay, J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm. J. 2017, 25, 830–837. [Google Scholar] [CrossRef]
- Ayeni, F.A.; Olugbake, O.A.; Ambeke, Y.P. Assessing the knowledge, attitude, and practice of hospital-based pharmacists in reporting adverse drug reactions in Lagos, Nigeria. Am. J. Pharmacother. Pharm. Sci. 2024, 3, 12. [Google Scholar] [CrossRef]
- Thilini Madhushika, M.; Jayasinghe, S.S.; Liyanage, P.G.C.; Dilan Malinda, W.A.; Abeykoon, P. Knowledge, Attitudes, and Practices of Adverse Drug Reaction Reporting Among Healthcare Professionals in Sri Lanka- A Cross Sectional Study. Hosp. Pharm. 2024, 59, 102–109. [Google Scholar] [CrossRef]
- Hughes, M.L.; Weiss, M. Adverse drug reaction reporting by community pharmacists—The barriers and facilitators. Pharmacoepidemiol. Drug Saf. 2019, 28, 1552–1559. [Google Scholar] [CrossRef]
- Al-Mutairi, A.; AlFayyad, I.; Altannir, Y.; Al-Tannir, M. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: A multi-center study. Arch. Public Health 2021, 79, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Abdulsalim, S.; Farooqui, M.; Alshammari, M.S.; Alotaibi, M.; Alhazmi, A.; Alqasomi, A.; Altowayan, W.M. Evaluation of knowledge, attitudes, and practices about pharmacovigilance among community pharmacists in Qassim, Saudi Arabia. Int. J. Environ. Res. Public Health 2023, 20, 3548. [Google Scholar] [CrossRef] [PubMed]
- Khan, L.M.; Al-Harthi, S.E.; Saadah, O.I. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Saudi Pharm. J. 2013, 21, 261–266. [Google Scholar] [CrossRef] [PubMed]
- Al-Hazmi, N.; Naylor, I. Attitude and awareness of adverse drug reaction reporting by health professionals in seven hospitals in the Holy City of Makkah, Kingdom of Saudi Arabia. J. Clin. Trials 2013, 3, 1–5. [Google Scholar] [CrossRef]
- Faqihi, M.A.J.; Fageehi, W.A. Pharmacist’s knowledge, attitude, and practice toward pharmacovigilance and adverse drug reactions reporting process: A cross-sectional survey. Int. J. Med. Dev. Ctries. 2019, 3, 409–414. [Google Scholar] [CrossRef]
- Tai, B.W.B.; Hata, M.; Wu, S.; Frausto, S.; Law, A.V. Prediction of pharmacist intention to provide medication disposal education using the theory of planned behaviour. J. Eval. Clin. Pract. 2016, 22, 653–661. [Google Scholar] [CrossRef]
- Aldryhim, A.Y.; Alomair, A.; Alqhtani, M.; Mahmoud, M.A.; Alshammari, T.M.; Pont, L.G.; Kamal, K.M.; Aljadhey, H.; Mekonnen, A.B.; Alwhaibi, M. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia. Expert Opin. Drug Saf. 2019, 18, 745–752. [Google Scholar] [CrossRef]
- Thakare, V.S.; Kavitha, V.; Langade, D. Prospective observational study to evaluate adverse drug reactions pattern in a tertiary level teaching hospital. Natl. J. Physiol. Pharm. Pharmacol. 2019, 9, 434. [Google Scholar] [CrossRef]
Sociodemographic Variables | Frequency | Percent |
---|---|---|
Age | Mean: 31.02 years old | SD: 5.61 |
Gender | ||
Female | 55 | 39% |
Male | 86 | 61% |
Educational Degree | ||
Diploma degree in pharmacy | 14 | 9.9% |
Bachelor’s degree in pharmacy | 41 | 29.1% |
Doctor of Pharmacy (PharmD) | 61 | 43.3% |
Graduate education degree in pharmacy | 25 | 17.7% |
Region of work in Saudi Arabia | ||
Western region | 66 | 46.8% |
Eastern region | 11 | 7.8% |
Central region | 39 | 27.7% |
Northern region | 4 | 2.8% |
Southern region | 21 | 14.9% |
Experience as pharmacist in hospital setting | ||
Fewer than 5 years | 66 | 46.8% |
From 5 to 10 years | 46 | 32.6% |
More than 10 years | 29 | 20.6% |
Number of pharmacists working in the same shift in the hospital pharmacy | ||
Fewer than 5 pharmacists | 63 | 44.7% |
From 5 to 10 pharmacists | 51 | 36.2% |
More than 10 pharmacists | 27 | 19.1% |
Awareness of the existence of NPC in Saudi Arabia | ||
Not aware | 19 | 13.5% |
Aware | 122 | 86.5% |
Familiar with the way of ADR reporting in Saudi Arabia | ||
Not Familiar | 35 | 24.8% |
Familiar | 106 | 75.2% |
Have you been trained to report ADRs before? | ||
No | 47 | 33.3% |
Yes | 94 | 66.7% |
Have you reported any ADRs to the Saudi NPC in in the previous 12 months? | ||
No | 99 | 70.2% |
Yes | 42 | 29.8% |
Variables | Disagree | Neutral | Agree |
---|---|---|---|
Intention | Mean: 6.20, SD: 1.20 Median: 7, IQR: 1.33 | ||
I intend to report serious ADRs that I will encounter to the Saudi NPC. | 4.3% | 7.8% | 87.9% |
I will try to report serious ADRs that I will encounter to the Saudi NPC. | 4.3% | 7.8% | 87.9% |
I plan to report serious ADRs that I will encounter to the Saudi NPC. | 7.1% | 7.8% | 85.1% |
Attitudes | Mean: 6.28, SD: 1.01 Median: 6.60, IQR: 1.20 | ||
Reporting ADRs to NPC in Saudi Arabia is valuable. | 6.4% | 4.3% | 89.4% |
Reporting ADRs to NPC in Saudi Arabia is pleasant. | 9.9% | 5.0% | 85.1% |
Reporting ADRs to NPC in Saudi Arabia is good. | 1.4% | 2.1% | 89.4% |
Reporting ADRs to NPC in Saudi Arabia is enjoyable. | 14.2% | 18.4% | 67.4% |
Reporting ADRs to NPC in Saudi Arabia is beneficial. | 3.5% | 2.8% | 93.6% |
Subjective Norms | Mean: 5.57, SD: 1.32 Median: 5.66, IQR: 2.33 | ||
Most people who are important to me think that I should report ADRs that I encounter to NPC in Saudi Arabia. | 13.5% | 24.8% | 61.7% |
The people in my life whose opinions I value would approve my reporting of ADRs that I encounter to NPC in Saudi Arabia. | 4.3% | 14.9% | 80.9% |
The pharmacists whose opinions I value report ADRs to NPC in Saudi Arabia. | 8.5% | 19.9% | 71.6% |
Perceived Behavioral Control | Mean: 4.86, SD: 1.48 Median: 5, IQR: 2 | ||
You believe you have complete control over reporting ADRs that you encounter to NPC in Saudi Arabia. | 14.9% | 20.6% | 64.5% |
It is mostly up to me whether or not I report ADRs to NPC in Saudi Arabia. | 21.3% | 26.2% | 52.5% |
Perceived Moral Obligation | Mean: 6.18, SD: 1.34 Median: 7, IQR: 1 | ||
I believe I have a moral obligation to report ADRs that I will encounter to NPC in Saudi Arabia. | 3.5% | 11.3% | 85.1% |
Variables | Hospital Pharmacists with Low Intention to Report ADRs to the Saudi NPC (n = 62) | Hospital Pharmacists with High Intention to Report ADRs to the Saudi NPC (n = 79) | p-Value |
---|---|---|---|
Gender | 0.071 | ||
Female | 34.5% | 65.5% | |
Male | 50.0% | 50.0% | |
Educational Degree | 0.280 | ||
Diploma degree in pharmacy | 42.9% | 57.1% | |
Bachelor’s degree in pharmacy | 31.7% | 68.3% | |
Doctor of Pharmacy (PharmD) | 49.2% | 50.8% | |
Graduate education degree in pharmacy | 52.0% | 48.0% | |
Region of work in Saudi Arabia | 0.261 | ||
Western region | 48.5% | 51.5% | |
Eastern region | 36.4% | 63.6% | |
Central region | 48.7% | 51.3% | |
Northern region | 0.0% | 100.0% | |
Southern region | 33.3% | 66.7% | |
Experience as pharmacist in hospital setting | 0.931 | ||
Fewer than 5 years | 45.5% | 54.5% | |
From 5 to 10 years | 43.5% | 56.5% | |
More than 10 years | 41.4% | 58.6% | |
Number of pharmacists working in the same shift in the hospital pharmacy | 0.581 | ||
Fewer than 5 pharmacists | 42.9% | 57.1% | |
From 5 to 10 pharmacists | 49.0% | 51.0% | |
More than 10 pharmacists | 37.0% | 63.0% | |
Awareness of the existence of NPC in Saudi Arabia | 0.242 | ||
Not aware | 31.6% | 68.4% | |
Aware | 45.9% | 54.1% | |
Familiar with the way of ADR reporting in Saudi Arabia | 0.070 | ||
Not Familiar | 57.1% | 42.9% | |
Familiar | 39.6% | 60.4% | |
Have you been trained to report ADRs before? | 0.023 | ||
No | 57.4% | 42.6% | |
Yes | 37.2% | 62.8% | |
Have you reported any ADRs to the Saudi NPC in in the previous 12 months? | 0.097 | ||
No | 48.5% | 51.5% | |
Yes | 33.3% | 66.7% | |
Attitude | 0.007 | ||
Perceived low positive attitude | 56.1% | 43.9% | |
Perceived high positive attitude | 33.3% | 66.7% | |
Subjective norms | < 0.001 | ||
Perceived low subjective norms | 72.1% | 27.9% | |
Perceived high subjective norms | 22.5% | 77.5% | |
Perceived behavioral control | 0.123 | ||
Perceived low behavioral control | 50.7% | 49.3% | |
Perceived high behavioral control | 37.8% | 62.2% | |
Perceived moral obligation | < 0.001 | ||
Perceived low moral obligation | 80.4% | 19.6% | |
Perceived high moral obligation | 23.3% | 76.7% |
Predictor Variables | Coefficient | SE | Wald | OR | Lower 95% CI | Upper 95% CI | p-Value |
---|---|---|---|---|---|---|---|
Attitude | |||||||
Perceived low positive attitude | Reference | ||||||
Perceived high positive attitude | 0.45 | 0.46 | 0.96 | 1.57 | 0.63 | 3.89 | 0.327 |
Subjective norms | |||||||
Perceived low subjective norms | Reference | ||||||
Perceived high subjective norms | 2.00 | 0.54 | 13.42 | 7.42 | 2.54 | 21.69 | <0.001 |
Perceived behavioral control | |||||||
Perceived low behavioral control | Reference | ||||||
Perceived high behavioral control | −0.96 | 0.56 | 2.88 | 0.38 | 0.12 | 1.16 | 0.090 |
Perceived moral obligation | |||||||
Perceived low moral obligation | Reference | ||||||
Perceived high moral obligation | 2.05 | 0.47 | 18.80 | 7.83 | 3.09 | 19.86 | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alsulami, F.T. Hospital Pharmacists’ Attitudes and Intentions Toward Adverse Drug Reaction Reporting in Saudi Arabia: Insights from the Theory of Planned Behavior. Healthcare 2025, 13, 1111. https://doi.org/10.3390/healthcare13101111
Alsulami FT. Hospital Pharmacists’ Attitudes and Intentions Toward Adverse Drug Reaction Reporting in Saudi Arabia: Insights from the Theory of Planned Behavior. Healthcare. 2025; 13(10):1111. https://doi.org/10.3390/healthcare13101111
Chicago/Turabian StyleAlsulami, Fahad T. 2025. "Hospital Pharmacists’ Attitudes and Intentions Toward Adverse Drug Reaction Reporting in Saudi Arabia: Insights from the Theory of Planned Behavior" Healthcare 13, no. 10: 1111. https://doi.org/10.3390/healthcare13101111
APA StyleAlsulami, F. T. (2025). Hospital Pharmacists’ Attitudes and Intentions Toward Adverse Drug Reaction Reporting in Saudi Arabia: Insights from the Theory of Planned Behavior. Healthcare, 13(10), 1111. https://doi.org/10.3390/healthcare13101111